Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures-Reference-Cited by-同舟云学术

Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures

Published:2016-03 Issue: Volume:25 Page:88-102
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Souverein Patrick C.¹,Abbing-Karahagopian Victoria¹,Martin Elisa²,Huerta Consuelo²,de Abajo Francisco³⁴,Leufkens Hubert G. M.¹⁵,Candore Gianmario⁶,Alvarez Yolanda⁶,Slattery Jim⁶,Miret Montserrat⁷,Requena Gema⁴,Gil Miguel J.²,Groenwold Rolf H. H.¹⁸,Reynolds Robert⁹,Schlienger Raymond G.¹⁰,Logie John W.¹¹,de Groot Mark C. H.¹^ORCID,Klungel Olaf H.¹⁸,van Staa Tjeerd P.¹¹²,Egberts Toine C. G.¹¹³,De Bruin Marie L.¹⁴,Gardarsdottir Helga¹¹³

Affiliation:

1. Division of Pharmacoepidemiology and Clinical Pharmacology; Utrecht University; The Netherlands

2. BIFAP Research Unit, Division of Pharmacoepidemiology and Pharmacovigilance; Agencia Española de Medicamentos y Productos Sanitarios (AEMPS); Madrid Spain

3. Clinical Pharmacology Unit; University Hospital Príncipe de Asturias; Madrid Spain

4. Department of Biomedical Sciences, School of Medicine and Health Sciences; University of Alcalá; Spain

5. MEB, Medicines Evaluation Board; Utrecht The Netherlands

6. EMA, European Medicines Agency; London United Kingdom

7. Merck KGaA; Geneva Switzerland

8. Julius Center for Health Sciences and Primary Care; University Medical Center Utrecht; Utrecht The Netherlands

9. Department of Epidemiology; Pfizer; New York United States

10. Global Clinical Epidemiology; Novartis Pharma AG; Basel Switzerland

11. Institute of Population Health; University of Manchester; Manchester United Kingdom

12. Worldwide Epidemiology; GlaxoSmithKline; Stockley Park United Kingdom

13. Department of Clinical Pharmacy, Division of Laboratory and Pharmacy; University Medical Center Utrecht; Utrecht The Netherlands

Funder

Innovative Medicine Initiative Joint Undertaking

Pfizer

AstraZeneca

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference30 articles.

1. Indications for antidepressant drug prescribing in general practice in the Netherlands;Gardarsdottir;J Affect Disord,2007

2. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications;Abbing-Karahagopian;Eur J Clin Pharmacol,2014

3. Antidepressants and falls in the elderly;Darowski;Drugs Aging,2009

4. Antidepressant medications and osteoporosis;Rizzoli;Bone,2012

5. Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA;Prieto-Alhambra;Osteoporos Int,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoporosis and Fracture Risk Associated with Novel Antidepressants: A Systematic Review and Meta-Analysis;Actas Españolas de Psiquiatría;2024-06-05

2. Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis;Healthcare;2022-04-26

3. Risk of ischaemic stroke among new users of glucosamine and chondroitin sulphate: a nested case–control study;Therapeutic Advances in Musculoskeletal Disease;2022-01

4. Risk of fracture in antidepressant users with concurrent use of benzodiazepines: A self-controlled case-series analysis;Bone;2021-12

5. Bias of time‐varying exposure effects due to time‐varying covariate measurement strategies;Pharmacoepidemiology and Drug Safety;2021-08